Kawasaki, Japan

Masahiro Yamanashi

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Yamanashi. Retrieved from https://idiyas.com/inventor/masahiro-yamanashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiro Yamanashi: Innovator in Anticoagulant Research

Introduction

Masahiro Yamanashi is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticoagulants. His innovative work has led to the creation of compounds that have the potential to improve blood coagulation therapies.

Latest Patents

Yamanashi holds a patent for benzamidine derivatives, which are compounds that exhibit a blood-coagulation inhibiting effect. These derivatives are characterized by their ability to inhibit the action of activated blood coagulation factor X. This property makes them valuable as anticoagulants, providing a new avenue for therapeutic applications in managing blood coagulation disorders. He has 1 patent to his name.

Career Highlights

Yamanashi is associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to focus on research and development in the area of anticoagulants, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Yamanashi has collaborated with notable colleagues, including Masaru Takayanagi and Kazuyuki Sagi. These collaborations have fostered a productive research environment, leading to innovative solutions in the pharmaceutical sector.

Conclusion

Masahiro Yamanashi's contributions to anticoagulant research exemplify the impact of innovation in the pharmaceutical industry. His work continues to pave the way for advancements in medical therapies that can benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…